Steven J Rockoff, MD
Diagnostic Radiology · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Ctr-Davies Campus Hosp · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rockoff’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A156278 · Current
Licensed to practise in California · since 2018 · expires 2028-06-30 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$598,409
Medicare paid this office $598,409 for 2,570 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening mammography | 1,762 | $260,238 | $148 |
| Screening 3d breast mammography | 1,758 | $101,700 | $58 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 31 | $49,399 | $1,544 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 46 | $20,620 | $448 |
| Limited ultrasound scan of 1 breast | 208 | $16,422 | $78 |
See all 28 services
| Screening mammography | 1,762 | $260,238 | $148 |
| Screening 3d breast mammography | 1,758 | $101,700 | $58 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 31 | $49,399 | $1,544 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 46 | $20,620 | $448 |
| Limited ultrasound scan of 1 breast | 208 | $16,422 | $78 |
| Diagnostic mammography of both breasts | 141 | $15,672 | $110 |
| Mri scan of both breasts | 44 | $14,110 | $314 |
| Diagnostic mammography of 1 breast | 137 | $12,657 | $90 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 36 | $10,412 | $281 |
| Ct scan of abdomen and pelvis with contrast | 38 | $10,186 | $268 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 260 | $8,831 | $34 |
| Placement of locating device in breast using ultrasound guidance, first growth | 18 | $5,723 | $318 |
| Complete ultrasound scan of 1 breast | 49 | $5,244 | $107 |
| Ultrasound scan of head and neck soft tissue | 56 | $4,775 | $84 |
| Mri scan of abdomen before and after contrast | 15 | $4,623 | $308 |
| Low dose ct scan of chest for lung cancer screening | 19 | $3,054 | $161 |
| Ct scan of chest without contrast | 28 | $3,018 | $108 |
| Dxa bone density measurement of hip, pelvis, spine | 65 | $2,932 | $45 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 25 | $2,913 | $117 |
| Ct scan of chest with contrast | 25 | $2,531 | $101 |
| Ultrasound of both sides of head and neck blood flow | 15 | $2,320 | $155 |
| Ct scan of abdomen and pelvis with contrast | 27 | $1,832 | $68 |
| Injection, gadobutrol, 0.1 ml | 57 | $1,174 | $0 |
| Limited ultrasound scan of abdomen | 15 | $1,038 | $65 |
| X-ray of chest, 2 views | 34 | $802 | $24 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 54 | $598 | $0 |
| X-ray of shoulder, minimum of 2 views | 11 | $357 | $30 |
| X-ray of chest, 1 view | 54 | $337 | $6 |
Who their Medicare patients are
2,570 Original Medicare patients in 2024. Average age 72 · Under 65 7% · 85 and older 4% · Women 91% · Also on Medicaid 16% · Health risk score 0.91. At or below the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 54% · Cancer 18% · Depression 18% · Diabetes 16% · Coronary heart disease 14% · Chronic kidney disease 13% · Atrial fibrillation 11% · COPD 9% · Heart failure 7% · Stroke 5% · Dementia 2%.
The office billed $2,877,433, Medicare allowed $680,998 and paid $598,409; for 15,820 services of 94 kinds; $2,270 of it was for drugs given in the office and $596,139 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,570 | 15,820 | 72 | 0.91 | $2,877,433 | $598,409 |
| 2023 | 2,442 | 13,124 | 72 | 0.90 | $2,488,061 | $559,840 |
| 2022 | 2,636 | 10,532 | 72 | 0.91 | $2,568,749 | $597,670 |
| 2021 | 2,397 | 9,279 | 72 | 0.88 | $2,170,925 | $541,327 |
| 2020 | 1,192 | 5,806 | 71 | 0.95 | $1,122,198 | $281,519 |
| 2019 | 277 | 389 | 71 | 3.08 | $77,142 | $10,373 |
| 2018 | 375 | 535 | 70 | 2.61 | $80,528 | $11,205 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 32 services
| Screening mammography | 1,663 | $253,136 | $152 |
| Screening 3d breast mammography | 1,661 | $100,341 | $60 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 15 | $24,588 | $1,537 |
| Diagnostic mammography of both breasts | 155 | $20,557 | $133 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 40 | $19,591 | $478 |
| Limited ultrasound scan of 1 breast | 214 | $18,595 | $83 |
| Mri scan of both breasts | 41 | $14,541 | $323 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 283 | $12,563 | $43 |
| Diagnostic mammography of 1 breast | 133 | $12,484 | $92 |
| Ct scan of abdomen and pelvis with contrast | 27 | $8,178 | $292 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 14 | $6,670 | $476 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 19 | $5,756 | $288 |
| Complete ultrasound scan of 1 breast | 38 | $4,445 | $117 |
| Placement of locating device in breast using imaging guidance, first growth | 17 | $3,822 | $225 |
| Dxa bone density measurement of hip, pelvis, spine | 82 | $3,699 | $45 |
| Ultrasound scan of head and neck soft tissue | 39 | $3,679 | $94 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 25 | $2,903 | $112 |
| Ct scan of chest without contrast | 23 | $2,474 | $108 |
| Ct scan of chest with contrast | 20 | $2,283 | $109 |
| Low dose ct scan of chest for lung cancer screening | 12 | $2,006 | $167 |
| Ultrasound scan of abdominal aorta | 11 | $1,400 | $127 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 12 | $1,209 | $101 |
| Complete ultrasound scan of abdomen | 13 | $1,146 | $88 |
| Complete ultrasound scan of pelvis | 13 | $1,102 | $85 |
| Injection, gadobutrol, 0.1 ml | 51 | $1,018 | $0 |
| X-ray of chest, 2 views | 34 | $952 | $27 |
| Ct scan of abdomen and pelvis with contrast | 11 | $670 | $61 |
| Ultrasonic guidance for needle placement | 11 | $584 | $53 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 39 | $500 | $0 |
| X-ray of knee, 3 views | 15 | $466 | $26 |
| X-ray of chest, 1 view | 56 | $368 | $7 |
| X-ray of foot, minimum of 3 views | 11 | $326 | $30 |
2022: 30 services
| Screening mammography | 1,749 | $265,494 | $151 |
| Screening 3d breast mammography | 1,751 | $105,242 | $60 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 20 | $31,914 | $1,520 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 51 | $25,213 | $485 |
| Limited ultrasound scan of 1 breast | 276 | $24,516 | $78 |
| Diagnostic mammography of both breasts | 162 | $21,147 | $127 |
| Mri scan of both breasts | 50 | $17,494 | $330 |
| Diagnostic mammography of 1 breast | 162 | $16,460 | $99 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 318 | $14,221 | $43 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 15 | $6,764 | $451 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 22 | $6,406 | $279 |
| Placement of locating device in breast using imaging guidance, first growth | 24 | $5,371 | $224 |
| Complete ultrasound scan of 1 breast | 35 | $4,488 | $90 |
| Ct scan of abdomen and pelvis with contrast | 14 | $4,213 | $301 |
| Dxa bone density measurement of hip, pelvis, spine | 74 | $3,223 | $44 |
| Ultrasound scan of head and neck soft tissue | 36 | $3,115 | $87 |
| Low dose ct scan of chest for lung cancer screening | 14 | $2,329 | $166 |
| Ct scan of chest without contrast | 16 | $1,842 | $115 |
| Complete ultrasound scan of abdomen | 17 | $1,785 | $105 |
| Ct scan of chest with contrast | 12 | $1,245 | $104 |
| Complete ultrasound scan behind abdominal cavity | 13 | $1,140 | $88 |
| Injection, gadobutrol, 0.1 ml | 54 | $843 | $0 |
| X-ray of chest, 2 views | 30 | $767 | $26 |
| X-ray of knee, 3 views | 19 | $660 | $26 |
| X-ray of chest, 1 view | 75 | $582 | $7 |
| Ultrasonic guidance for needle placement | 11 | $581 | $53 |
| X-ray of shoulder, minimum of 2 views | 11 | $227 | $21 |
| Imaging guidance for procedure, 60 minutes or less | 17 | $220 | $13 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19 | $174 | $0 |
| X-ray of chest, 2 views | 16 | $101 | $6 |
2021: 28 services
| Screening mammography | 1,629 | $250,053 | $153 |
| Screening 3d breast mammography | 1,630 | $100,771 | $62 |
| Limited ultrasound scan of 1 breast | 270 | $24,766 | $80 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 14 | $20,852 | $1,489 |
| Diagnostic mammography of both breasts | 156 | $19,712 | $126 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 33 | $17,938 | $544 |
| Diagnostic mammography of 1 breast | 143 | $14,652 | $102 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 295 | $13,885 | $46 |
| Mri scan of both breasts | 34 | $11,901 | $350 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 18 | $9,495 | $528 |
| Ct scan of abdomen and pelvis with contrast | 16 | $4,962 | $310 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 15 | $4,274 | $285 |
| Ultrasound scan of head and neck soft tissue | 31 | $3,436 | $107 |
| Placement of locating device in breast using imaging guidance, first growth | 13 | $2,767 | $213 |
| Complete ultrasound scan of 1 breast | 23 | $2,692 | $69 |
| Dxa bone density measurement of hip, pelvis, spine | 58 | $2,565 | $44 |
| Ct scan of chest with contrast | 12 | $1,400 | $117 |
| Complete ultrasound scan of abdomen | 15 | $1,366 | $91 |
| X-ray of chest, 2 views | 35 | $963 | $27 |
| Limited ultrasound scan of abdomen | 12 | $932 | $78 |
| Ct scan of abdomen and pelvis with contrast | 11 | $767 | $70 |
| X-ray of knee, 3 views | 13 | $717 | $31 |
| X-ray of chest, 1 view | 67 | $508 | $7 |
| Ct scan head or brain without contrast | 16 | $497 | $31 |
| Injection, gadobutrol, 0.1 ml | 51 | $428 | $0 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 27 | $277 | $0 |
| Imaging guidance for procedure, 60 minutes or less | 12 | $157 | $13 |
| X-ray of chest, 2 views | 11 | $83 | $7 |
2020: 14 services
| Screening mammography | 850 | $128,113 | $149 |
| Screening 3d breast mammography | 849 | $50,610 | $59 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 29 | $16,401 | $547 |
| Diagnostic mammography of both breasts | 97 | $13,314 | $137 |
| Limited ultrasound scan of 1 breast | 129 | $11,012 | $78 |
| Mri scan of both breasts | 30 | $10,840 | $350 |
| Diagnostic mammography of 1 breast | 82 | $8,122 | $99 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 176 | $8,047 | $45 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 11 | $5,984 | $544 |
| Ct scan of abdomen and pelvis with contrast | 15 | $4,372 | $291 |
| Ct scan of chest with contrast | 14 | $1,681 | $120 |
| Injection, gadobutrol, 0.1 ml | 36 | $399 | $0 |
| X-ray of chest, 1 view | 29 | $210 | $7 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19 | $156 | $0 |
2019: 9 services
| Ct scan of abdomen and pelvis with contrast | 44 | $2,948 | $67 |
| Ct scan of blood vessels of chest with contrast | 17 | $1,190 | $70 |
| X-ray of chest, 1 view | 98 | $1,072 | $8 |
| Ct scan of abdomen and pelvis without contrast | 13 | $934 | $72 |
| Ct scan of chest with contrast | 18 | $838 | $47 |
| Ct scan of lower spine without contrast | 12 | $472 | $39 |
| Limited ultrasound scan of abdomen | 16 | $378 | $24 |
| X-ray of abdomen, 1 view | 22 | $211 | $8 |
| X-ray of chest, 2 views | 21 | $189 | $9 |
2018: 8 services
| Ct scan of abdomen and pelvis with contrast | 50 | $3,875 | $75 |
| X-ray of chest, 1 view | 174 | $1,525 | $8 |
| Ct scan of abdomen and pelvis without contrast | 14 | $994 | $71 |
| Ct scan of chest with contrast | 14 | $690 | $49 |
| Ct scan of lower spine without contrast | 12 | $470 | $39 |
| X-ray of abdomen, 1 view | 54 | $443 | $8 |
| X-ray of chest, 2 views | 43 | $386 | $9 |
| Limited ultrasound scan of abdomen | 12 | $285 | $24 |
Medicaid work
$9,141 in 2024
Medicaid paid $9,141 for 165 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 91 | $3,658 |
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 19 | $3,188 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 19 | $1,290 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 36 | $1,004 |
| 2024 | 165 | 4 | 17 | $9,141 |
| 2023 | 2,745 | 6 | 79 | $175,420 |
| 2022 | 4,570 | 7 | 77 | $256,354 |
| 2021 | 3,830 | 6 | 74 | $218,672 |
| 2020 | 1,750 | 5 | 55 | $99,222 |
| 2019 | 255 | 4 | 40 | $3,706 |
| 2018 | 337 | 5 | 36 | $3,758 |
See the largest Medicaid services in earlier years
2023
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 957 | $91,516 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 954 | $39,664 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 375 | $19,220 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ BI | 149 | $13,549 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 279 | $9,233 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ UNI | 31 | $2,238 |
2022
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 1,122 | $91,691 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 983 | $49,030 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 1,124 | $41,584 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ BI | 449 | $39,376 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 702 | $22,717 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ UNI | 177 | $11,811 |
| Radiologic examination, chest; single view | 13 | $145 |
2021
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 1,060 | $89,541 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 1,107 | $42,203 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 784 | $38,585 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ BI | 266 | $24,166 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 498 | $16,085 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ UNI | 115 | $8,092 |
2020
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 442 | $36,876 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ BI | 204 | $18,867 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 497 | $18,433 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 334 | $16,238 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 273 | $8,809 |
2019
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 47 | $2,525 |
| Radiologic examination, chest; single view | 152 | $862 |
| Radiologic examination, chest; 2 views | 35 | $205 |
| X-ray of abdomen, 1 view | 21 | $114 |
2018
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 43 | $1,670 |
| Radiologic examination, chest; single view | 186 | $1,319 |
| Radiologic examination, chest; 2 views | 62 | $310 |
| ECHO EXAM OF ABDOMEN | 12 | $285 |
| X-ray of abdomen, 1 view | 34 | $175 |
Money from drug and device companies
$19 in 2025
| 2025 | 1 | 1 | None | $19 |
| 2024 | 1 | 2 | None | $38 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Magseed | $19 | 1 payment
|
See the published payment
| Hologic Sales and Service | Meals · 2025-07-15 | Magseed | $19 |
See earlier years (2024)
2024: $38
| Hologic Sales and Service | Localizer | $38 | 2 payments
|
Professional record
- NPI
- 1336481886
- Licence
- CA A156278California A156278: Current · expires 2028-06-30
- Trained
- New York Medical College, 2013
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 1336481886
- Taxonomy
- Diagnostic radiology (2085R0202X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2013-03-22
- NPI last updated
- 2021-04-29
- NPI record certified
- 2021-04-29
This is when the NPI record was last certified, not a medical board exam.